Journal rankings · indicator year 2018
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2018
Pharmacology, Toxicology and Pharmaceutics journal rankings 2018
73 ranked journals · Field in Life Sciences
Pharmacology, Toxicology and Pharmaceutics has 73 ranked journals in 2018. The median journal has an OJR of 0.74, below the world average of 1.00, up 0.03 on 2017; Q1 starts at OJR 1.04. The top three are European Journal of Pharmaceutics and Biopharmaceutics, Expert Opinion on Drug Delivery, and Drug Safety.
Ranks and citation indicators: 2018. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2015–2017, the window the 2018 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Pharmacology, Toxicology and Pharmaceutics (4)
Up to Life Sciences73 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2017. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2015–2017, the window the 2018 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2015–2017 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2009 to 2018. | Compare |
|---|---|---|---|---|---|---|---|
1European Journal of Pharmaceutics and BiopharmaceuticsElsevier BV · Netherlands | 2.01Q1 | 4.76 0.08 down from 2017 | 892 | 29% | $4,210 | ||
2Expert Opinion on Drug DeliveryTaylor & Francis · United Kingdom | 1.88Q1 | 5.27 0.53 up from 2017 | 349 | 31% | — | ||
3Drug SafetyAdis, Springer Healthcare · New Zealand | 1.75Q1 | 3.79 0.40 down from 2017 | 348 | 47% | $4,990 | ||
4Pharmaceutical ResearchSpringer Science+Business Media · United States | 1.66Q1 | 4.64 0.90 up from 2017 | 640 | 40% | $4,690 | ||
5International Journal of PharmaceuticsElsevier BV · Netherlands | 1.64Q1 | 4.71 0.66 up from 2017 | 2,691 | 26% | $4,650 | ||
6Clinical and Translational ScienceOAWiley · United Kingdom | 1.63Q1 | 3.81 1.52 up from 2017 | 236 | 100% | $3,630 | ||
7Drug DeliveryOATaylor & Francis · United Kingdom | 1.53Q1 | 4.50 0.62 up from 2017 | 425 | 100% | $2,864 | ||
8Drug Metabolism and DispositionAmerican Society for Pharmacology and Experimental Therapeutics · United States | 1.50Q1 | 3.48 0.21 down from 2017 | 572 | 86% | $3,500 | ||
9Journal of Analytical ToxicologyOxford University Press · United Kingdom | 1.48Q1 | 3.40 0.71 up from 2017 | 380 | 27% | $4,823 | ||
10European Journal of Pharmaceutical SciencesOAElsevier BV · Netherlands | 1.47Q1 | 3.68 0.03 down from 2017 | 1,195 | 21% | $3,070 | ||
11Expert Opinion on Drug Metabolism & ToxicologyTaylor & Francis · United Kingdom | 1.43Q1 | 3.67 0.23 up from 2017 | 371 | 25% | — | ||
12Expert Opinion on Drug SafetyTaylor & Francis · United Kingdom | 1.41Q1 | 3.71 0.14 up from 2017 | 465 | 24% | — | ||
13Forensic ToxicologySpringer Science+Business Media · Japan | 1.31Q1 | 2.51 0.60 down from 2017 | 145 | 48% | $2,990 | ||
14Pharmacogenetics and GenomicsLippincott Williams & Wilkins · United Kingdom | 1.26Q1 | 2.92 0.48 up from 2017 | 208 | 40% | — | ||
15The Pharmacogenomics JournalSpringer Nature · United Kingdom | 1.19Q1 | 2.93 0.51 down from 2017 | 255 | 40% | $4,890 | ||
16Drug Delivery and Translational ResearchSpringer Science+Business Media · United States | 1.17Q1 | 2.74 0.53 down from 2017 | 250 | 29% | $4,690 | ||
17Forensic ChemistryElsevier BV · Netherlands | 1.10Q1 | 2.14 0.64 up from 2017 | 86 | 18% | $4,530 | ||
18Drug Testing and AnalysisWiley · United States | 1.04Q1 | 2.51 0.20 down from 2017 | 533 | 24% | $4,440 | ||
19Journal of Pharmaceutical InnovationSpringer Science+Business Media · United Kingdom | 1.04Q1 | 1.33 1.05 down from 2017 | 95 | 8% | $3,990 | ||
20Critical Reviews in Therapeutic Drug Carrier SystemsBegell House · United States | 1.03Q2 | 2.79 0.01 down from 2017 | 47 | 3% | — | ||
21Current Drug MetabolismBentham Science Publishers · Netherlands | 1.02Q2 | 2.38 0.29 down from 2017 | 283 | 10% | — | ||
22Journal of Drug Delivery Science and TechnologyElsevier BV · France | 1.02Q2 | 2.67 0.27 up from 2017 | 576 | 5% | $3,810 | ||
23AAPS PharmSciTechSpringer Science+Business Media · United States | 0.99Q2 | 2.37 0.17 up from 2017 | 661 | 18% | $4,190 | ||
24Journal of PharmaceuticsOAHindawi Publishing Corporation · United Kingdom | 0.99Q2 | 2.24 1.50 up from 2017 | 33 | 100% | — | ||
25Future Journal of Pharmaceutical SciencesOASpringer Science+Business Media · Egypt | 0.91Q2 | 2.19 0.09 down from 2017 | 45 | 100% | $0 listed | ||
26PharmacogenomicsFuture Medicine · United Kingdom | 0.89Q2 | 2.25 0.26 down from 2017 | 515 | 43% | — | ||
27Drug Development and Industrial PharmacyTaylor & Francis · United States | 0.88Q2 | 2.16 0.08 up from 2017 | 559 | 20% | — | ||
28Journal of Pharmaceutical InvestigationSpringer Science+Business Media · South Korea | 0.87Q2 | 2.73 0.10 down from 2017 | 210 | 17% | $3,890 | ||
29Drug Metabolism and PharmacokineticsElsevier BV · Japan | 0.87Q2 | 2.03 0.39 up from 2017 | 161 | 3% | $3,580 | ||
30Journal of Pharmaceutical Health Care and SciencesOABioMed Central · United Kingdom | 0.87Q2 | 1.55 0.02 down from 2017 | 94 | 100% | $2,490 | ||
31Therapeutic DeliveryFuture Science Ltd · United Kingdom | 0.86Q2 | 2.14 0.19 down from 2017 | 286 | 36% | — | ||
32Journal of Drug DeliveryHindawi Publishing Corporation · United Kingdom | 0.84Q2 | 2.56 0.98 up from 2017 | 37 | 50% | — | ||
33Journal of MicroencapsulationTaylor & Francis · United Kingdom | 0.83Q2 | 2.05 0.06 down from 2017 | 219 | 7% | — | ||
34Biopharmaceutics & Drug DispositionWiley · United Kingdom | 0.81Q2 | 1.72 0.05 up from 2017 | 144 | 22% | $3,800 | ||
35European Journal of Drug Metabolism and PharmacokineticsAdis, Springer Healthcare · France | 0.77Q2 | 1.86 0.46 up from 2017 | 197 | 27% | $2,690 | ||
36Pharmaceutical Development and TechnologyTaylor & Francis · United States | 0.75Q2 | 1.81 0.15 up from 2017 | 320 | 21% | — | ||
37Scientia PharmaceuticaOAÖsterreichische Apotheker-Verlagsgesellschaft m. b. H. · Switzerland | 0.75Q2 | 2.20 1.26 up from 2017 | 144 | 100% | $1,207 | ||
38XenobioticaTaylor & Francis · United Kingdom | 0.71Q3 | 1.59 0.03 down from 2017 | 451 | 24% | — | ||
39Journal of Fluorine ChemistryElsevier BV · Netherlands | 0.69Q3 | 1.95 0.06 up from 2017 | 681 | 14% | $3,660 | ||
40Assay and Drug Development TechnologiesMary Ann Liebert, Inc. · United States | 0.65Q3 | 1.58 0.24 down from 2017 | 169 | 24% | — | ||
41Drug Metabolism LettersBentham Science Publishers · Netherlands | 0.62Q3 | 1.31 0.28 up from 2017 | 73 | 52% | — | ||
42Current Drug DeliveryBentham Science Publishers · Netherlands | 0.57Q3 | 1.44 0.17 down from 2017 | 375 | 16% | — | ||
43Drug Metabolism and Personalized TherapyDe Gruyter · Germany | 0.57Q3 | 1.05no change | 84 | 29% | $2,712 | ||
44Recent Patents on NanotechnologyBentham Science Publishers · Netherlands | 0.50Q3 | 1.13 0.16 up from 2017 | 93 | 4% | — | ||
45International Journal of Pharmacy and Pharmaceutical SciencesOAInnovare Academic Sciences · India | 0.45Q3 | 1.03 0.30 up from 2017 | 1,950 | 100% | — | ||
46Medicinal ChemistryOMICS Publishing Group | 0.40Q3 | 0.65 0.29 down from 2017 | 283 | 13% | — | ||
47Brazilian Journal of Pharmaceutical SciencesOAUniversity of São Paulo · Brazil | 0.39Q3 | 0.83 0.33 up from 2017 | 314 | 100% | — | ||
48Recent Patents on Drug Delivery & FormulationBentham Science Publishers · Netherlands | 0.35Q3 | 0.67 0.25 down from 2017 | 71 | 0% | — | ||
49ADMET & DMPKOAInternational Association of Physical Chemists (IAPC) · Croatia | 0.34Q3 | 1.12 0.41 up from 2017 | 71 | 100% | — | ||
50Indian Journal of Pharmaceutical Education and ResearchAssociation of Pharmaceutical Teachers of India · India | 0.34Q3 | 0.69 0.07 up from 2017 | 381 | 86% | — |
Subfields of Pharmacology, Toxicology and Pharmaceutics, compared.
Journals
Citations made in 2018. Corpus-wide, 81.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
29 additional Pharmacology, Toxicology and Pharmaceutics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2015–2017, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2018. Publication window: 2015–2017. How these summaries are calculated
- Ranked journals
- 73
- Window papers (baseline)
- 53,536 -10.3% from indicator year 2015
- Median OJR
- 0.74 +3.5% from indicator year 2015
- Rising journals (2025)
- 4Comparison-group list (4)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2015–2017 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 23 | 27 | 30 | 32 | 32 | 34 | 37 | 38 | 40 | 43 | 44 | 49 | 54 | 61 | 69 | 71 | 74 | 71 | 73 | 75 | 70 | 72 | 75 | 73 | 72 | 68 | |
| Window papers (baseline) | 20,428 | 21,714 | 23,158 | 25,397 | 26,889 | 29,157 | 31,606 | 34,777 | 38,146 | 41,640 | 45,814 | 49,553 | 53,613 | 56,245 | 59,173 | 59,681 | 59,061 | 56,321 | 53,536 | 51,719 | 51,606 | 54,267 | 56,608 | 57,539 | 56,944 | 58,541 | |
| Median OJR | 0.620 | 0.717 | 0.722 | 0.88 | 0.86 | 0.83 | 0.91 | 1.11 | 0.9471 | 0.97 | 0.949 | 1.03 | 0.9469 | 0.80 | 0.70 | 0.720 | 0.61 | 0.7184 | 0.74 | 0.628 | 0.77 | 0.621 | 0.67 | 0.630 | 0.625 | 0.7176 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 2.7% | 62 journals |
| Retracted papers per 1,000 | Pooled rate: 1.221 per 1,000 | 51 journals |
| Output growth | Median: -1.6% | 60 journals |
| Open access share | Median: 44.5% | 68 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,605 | 32 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 22.2% | 67 journals |
| Review share | Median: 0.4% | 68 journals |
| Articles-only OJR | Median: 0.74 | 68 journals |
| Uncited share | Median: 25.2% | 68 journals |
| Citation concentration | Median: 43.7% | 68 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.